Dafodil Tri-Leaflet Stented Bioprosthetic Aortic Valve

The Dafodil bioprosthesis, utilizing a tri-leaflet design and bovine pericardial tissue, is engineered for optimal hemodynamics. Accelerated wear testing demonstrates excellent durability and resistance to structural valve deterioration. Clinical data will provide further long-term insights into performance.

The Anti Ca™ proprietary treatment mitigates calcium binding to the bovine pericardial leaflets. This reduces the risk of leaflet calcification, a primary cause of bioprosthetic valve failure, thereby extending the valve's functional lifespan and improving biocompatibility.

The Elgiloy alloy wireform backbone of the Dafodil valve provides excellent radiopacity and structural support facilitating secure and precise placement within the aortic or mitral annulus. The valve's design is intended to simplify implantation, potentially reducing operative time.

This product is manufactured by Meril Life Sciences and is distributed by Agile Healthcare across all districts of Telangana.

Yes, all Meril Life Sciences products distributed by Agile Healthcare, including the Dafodil Tri-Leaflet Stented Bioprosthetic Aortic Valve, strictly adhere to CDSCO guidelines and ISO 13485:2016 quality standards.

The Dafodil Tri-Leaflet Stented Bioprosthetic Aortic Valve is constructed using Bovine pericardium, ensuring high biocompatibility and durability.